tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CGON Stock Latest News

Company AnnouncementsCG Oncology Advances in Bladder Cancer Therapeutics
8m ago
CGON
CG Oncology files automatic mixed securities shelf
PremiumThe Fly
CG Oncology files automatic mixed securities shelf
7h ago
CGON
PremiumRatings
Promising Clinical Data and Strong Financials Support Buy Rating for CG Oncology
9h ago
CGON
CG Oncology reports FY24 EPS ($1.41) vs ($15.65) last year
PremiumThe Fly
CG Oncology reports FY24 EPS ($1.41) vs ($15.65) last year
17h ago
CGON
PremiumRatings
Promising Phase 3 Trial Results and Strong Market Potential Drive Buy Rating for CG Oncology
4d ago
CGON
PremiumRatingsBuy Rating for CG Oncology: Promising Phase 3 Results and Strong Safety Profile of Cretostimogene
4d ago
CGON
Premium
Ratings
Buy Rating for CG Oncology Backed by Promising Phase 3 Study Results and Strong Safety Profile
4d ago
CGON
Premium
Company Announcements
CG Oncology’s Promising Phase 3 Trial Results Revealed
5d ago
8K
CGON
CG Oncology says 75.5% of patients achieve CR in Phase 3 study of cretostimogene
PremiumThe Fly
CG Oncology says 75.5% of patients achieve CR in Phase 3 study of cretostimogene
5d ago
CGON
CG Oncology assumed with an Overweight at Morgan Stanley
PremiumThe Fly
CG Oncology assumed with an Overweight at Morgan Stanley
22d ago
CGON
PremiumRatings
Buy Rating for CG Oncology: Promising Market Position and Upside Potential of Cretostimogene in NMIBC Treatment
22d ago
CGON
Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
PremiumThe Fly
Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
2M ago
ABT
BMY
PremiumCompany AnnouncementsCG Oncology Amends Key Executive Employment Agreements
3M ago
8K
CGON
Pfizer study impact on CG Oncology to be minimal, says H.C. Wainwright
Premium
The Fly
Pfizer study impact on CG Oncology to be minimal, says H.C. Wainwright
3M ago
PFE
CGON
CG Oncology initiated with a Buy at TD Cowen
Premium
The Fly
CG Oncology initiated with a Buy at TD Cowen
3M ago
CGON
CG Oncology 8M share Secondary priced at $28.00
PremiumThe Fly
CG Oncology 8M share Secondary priced at $28.00
4M ago
CGON
CG Oncology announces offering of 8M shares of common stock
PremiumThe Fly
CG Oncology announces offering of 8M shares of common stock
4M ago
CGON
CG Oncology files to sell 8M shares of common stock
PremiumThe Fly
CG Oncology files to sell 8M shares of common stock
4M ago
CGON
PremiumCompany Announcements
CG Oncology Reports Promising Phase 3 Trial Results
4M ago
8K
CGON
CG Oncology announces data from Phase 3 BOND-003 trial
PremiumThe FlyCG Oncology announces data from Phase 3 BOND-003 trial
4M ago
CGON
Premium
Company Announcements
CG Oncology’s Financial Results and Clinical Developments
4M ago
CGON
CG Oncology reports Q3 EPS (30c), consensus (37c)
Premium
The Fly
CG Oncology reports Q3 EPS (30c), consensus (37c)
5M ago
CGON

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >